Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Amgen operations head to retire after 25 years’ service

Amgen operations head to retire after 25 years’ service

3rd August 2007

Amgen has this week announced that its executive vice-president of operations, Dennis Fenton, will retire from the company at the end of this year, having spent 25 years of his career at Amgen.

The firm notes that in his time at Amgen, Mr Fenton worked and headed a number of units at the company, including sales and marketing, research, process development, engineering and manufacturing.

Having joined the business in its first year, Mr Fenton is one of the longest serving Amgen employees.

Mr Fenton will be replaced as head of operations by Dr Fabrizio Bonanni, who was appointed as senior vice-president of manufacturing at Amgen in March 2003. Dr Bonanni will be replaced in his role by Madhu Balachandran, formerly vic- president of operations at Amgen Manufacturing based in Puerto Rico.

Kevin Sharer, chairman and chief executive officer of Amgen, said: “Dennis will be deeply missed by all of us who have had the pleasure to work with him over the years.

“He has been one of the greatest champions of the Amgen values and a true ambassador of our heritage.”

He added that Mr Fenton has aided in the development of a dependable, well-organised and able biotechnology manufacturing business, for which the company is endlessly appreciative.

In May 2007, Amgen announced the appointment of David Lacey as senior vice-president and head of research of the firm.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.